 |
|
|
| |
Successful Treatment with Direct Acting Antivirals in HIV/HCV
Patients ....95% SVR with Sim/Sof in real-world clinic setting/support services
|
| |
| |
"......SVR12 rates in our cohort of HIV/HCV patients on SOF+SMV (95%) were comparable to those observed in the COSMOS trial although slightly higher than those reported in recent 'real world' studies (TRIO (89%) and HCV-TARGET (82%)). Closer monitoring of a dually infected population and a multi-disciplinary approach to treatment may account for our higher success rates."
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Jennifer Grant1; Valentina Stosor1; Frank Palella1; Richard Green2; Guajira Thomas1; Donna McGregor1; Milena McLaughlin3;
Sudhir Penugonda1; Michael Angarone1; Claudia Hawkins1
Divisions of Infectious Diseases1 and Hepatology2, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Midwestern University, Chicago College of Pharmacy3
|
| |
|
|
|
|
|
